AYTU BIOPHARMA, INC — Director's Dealing 2016

Jan 21, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AYTU BIOSCIENCE, INC (AYTU)
CIK: 0001385818
Period of Report: 2016-01-20

Reporting Person: Disbrow Joshua R. (Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-01-20	Common Stock	P	153846	$0.65	Acquired	153846	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Employee Stock Option Grant	$1.51	2025-11-11	Common Stock (600000)	600000	Direct

Footnotes

F1: These shares were purchased by the Reporting Person pursuant to a subscription agreement with the Issuer, dated January 20, 2016, which closed on January 20, 2016, and are restricted for resale indefinitely.

F2: 33.33% vests on the one year, two year and three year anniversary of the date of grant, subject to the Grantee's continued service as an employee on such dates.